{"raw_mentions": "As used herein, \u201cspecific binding\u201d refers to the binding of an antigen by an antibody with a dissociation constant (Kd) of about 1 \u03bcM or lower as measured, for example, by surface plasmon resonance (SPR)."}
{"final_json": [{"molecule_name": null, "protein_target_name": "antigen", "binding_metric": "Kd", "value": "<1", "unit": "\u03bcM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nADX_Y1072.ZZ0-1 has a KD_app value of 1.2E\u221207 M.\nADX_Y1238.ZZ0-1 has a KD_app value of 2.2E\u221209 M.\nADX_Y1258.ZZ0-1 has a KD_app value of 7.9E\u221209 M.\nADX_Y1260.ZZ0-1 has a KD_app value of 4.0E\u221209 M.\nADX_Y1262.ZZ0-1 has a KD_app value of 6.6E\u221209 M.\nADX_Y1264.ZZ0-1 has a KD_app value of 1.7E\u221208 M.\nADX_Y1267.ZZ0-1 has a KD_app value of 1.1E\u221209 M.\nADX_Y1268.ZZ0-1 has a KD_app value of 1.4E\u221209 M.\n\n\nNote that these sentences are based on the table rows, and I've rephrased them to include the molecule name, bioactivity metric, numeric value, and unit. Let me know if you'd like me to clarify or expand on this!"}
{"final_json": [{"molecule_name": "ADX_Y1072.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "1.2E\u221207", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1238.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "2.2E\u221209", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1258.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "7.9E\u221209", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1260.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "4.0E\u221209", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1262.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "6.6E\u221209", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1264.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "1.7E\u221208", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1267.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "1.1E\u221209", "unit": "M", "is_logarithmic": false}, {"molecule_name": "ADX_Y1268.ZZ0-1", "protein_target_name": null, "binding_metric": "KD_app", "value": "1.4E\u221209", "unit": "M", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nY12XX-hz28-P238K was also a potent antagonist of B cell proliferation stimulated with cellular CD40L from CD40L-expressing CHO cells, with an IC50 of 38.1 ng/ml and a standard deviation of 9.88 ng/ml.\nThe KD values for the binding of Y12XX-hCD40 to CD40 were 3.1 nM at 25\u00b0 C. and 5.5 nM at 37\u00b0 C.\nThe KD values for the binding of Y12XX-hz28 to CD40 were 4.4 nM at 25\u00b0 C. and 10.9 nM at 37\u00b0 C.\nThe KD values for the binding of Y12XX-hz40 to CD40 were 3.4 nM at 25\u00b0 C. and 8.5 nM at 37\u00b0 C.\nThe KD values for the binding of Y12XX-hz42 to CD40 were 2.3 nM at 25\u00b0 C. and 5.5 nM at 37\u00b0 C.\nAntibody B bound to CD40 with a KD of 37 nM at 25\u00b0 C.\nThe IC50 values for the inhibition of B cell proliferation induced by soluble CD40L trimer were 9.4 ng/ml for Antibody B, 6.7 ng/ml for Y12XX-hz28-P238K, 6.0 ng/ml for Y12XX-hz40-P238K, and 12.1 ng/ml for Y12XX-hz42-P238K.\nThe KD value for the binding of Antibody B to hCD16a-V158 was 7 \u03bcM."}
{"final_json": [{"molecule_name": "Y12XX-hz28-P238K", "protein_target_name": "CD40", "binding_metric": "IC50", "value": "38.1", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "Y12XX-hCD40", "protein_target_name": "CD40", "binding_metric": "KD", "value": "3.1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hCD40", "protein_target_name": "CD40", "binding_metric": "KD", "value": "5.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz28", "protein_target_name": "CD40", "binding_metric": "KD", "value": "4.4", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz28", "protein_target_name": "CD40", "binding_metric": "KD", "value": "10.9", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz40", "protein_target_name": "CD40", "binding_metric": "KD", "value": "3.4", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz40", "protein_target_name": "CD40", "binding_metric": "KD", "value": "8.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz42", "protein_target_name": "CD40", "binding_metric": "KD", "value": "2.3", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz42", "protein_target_name": "CD40", "binding_metric": "KD", "value": "5.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Antibody B", "protein_target_name": "CD40", "binding_metric": "KD", "value": "37", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Antibody B", "protein_target_name": null, "binding_metric": "IC50", "value": "9.4", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz28-P238K", "protein_target_name": null, "binding_metric": "IC50", "value": "6.7", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz40-P238K", "protein_target_name": null, "binding_metric": "IC50", "value": "6.0", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "Y12XX-hz42-P238K", "protein_target_name": null, "binding_metric": "IC50", "value": "12.1", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "Antibody B", "protein_target_name": "hCD16a-V158", "binding_metric": "KD", "value": "7", "unit": "\u03bcM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFor example, samples of purified antibody at 3 \u03bcg/ml concentration are first captured on the immobilized protein A surface using a 15 second (s) contact time at 10 \u03bcl/min flow rate. \nThis is followed by the binding of purified Fc\u03b3R-His proteins at various concentrations, such as 10 \u03bcM-1.5 nM (2:1 dilution series) or 10 \u03bcM-13.7 nM (2:1 dilution series), using 120 s association and dissociation times at a flow rate of 30\u03bc/min.\nThe monovalent CD40 binding affinity of the antibody molecules is measured by surface plasmon resonance (SPR) on a BIAcore\u2122 T200 instrument (GE Healthcare Life Sciences) at 25\u00b0 C. or 37\u00b0 C. by capturing antibody on an immobilized protein A sensor chip surface, and then binding human-CD40-monomer protein (generated in house) using, for example, an association time of 180 seconds, and dissociation time of 180 seconds or 360 seconds at 30 \u03bcl/min in PBS-T, pH 7.1. \nOne million of isolated monocytes were plated in each well of a 6-well plate in 6 mLs of complete media (RPMI-1640, 10% heat-inactivated fetal bovine serum, 100 units/ml penicillin-streptomycin), containing IL-4 (100 ng/ml) and GM-CSF (100 ng/ml) and incubated for 6 days at 37\u00b0 C./5% CO<sub>2</sub>, changing media every other day and replacing it with fresh media containing the same concentration of cytokines."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": null, "binding_metric": null, "value": "3", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Fc\u03b3R-His", "protein_target_name": null, "binding_metric": null, "value": "10 \u03bcM-1.5 nM", "unit": null, "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "CD40", "binding_metric": "binding affinity", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "IL-4", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "ng/ml", "is_logarithmic": false}, {"molecule_name": "GM-CSF", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "ng/ml", "is_logarithmic": false}]}
